News | February 20, 2020

ATC By Pfeiffer Vacuum Receives FDA Approval For Pharmaceutical Package Leak Testing


Companies utilizing this technology do not need to submit leak testing approval application to FDA

Pfeiffer Vacuum, one of the world's leading providers of vacuum technology, has announced that the ATC by Pfeiffer Vacuum Mass Extraction leak testing process meets FDA standard F3287 for leak testing. This shortens the FDA approval process for pharmaceutical products that require leak testing significantly. Companies that utilize the ATC leak testing process will save hundreds of hours of paperwork for the approval application.

When a pharmaceutical company launches a new product or changes an existing product, FDA approval is required. Normally, companies have to submit extensive documentation. However, with ATC being added to the FDA standard, companies do not need to submit paperwork regarding leak test, test procedure, water ingress, and package testing manufacturers can simply declare that their product is leak tested in accordance with FDA F3287 by using ATC equipment, thus adhering to the standard.

“It is a tremendous advantage for companies in the pharmaceutical market that utilize ATC’s technology since they save time and costs,” said Brian Pahl, President of the ATC by Pfeiffer Vacuum product line.

Mass Extraction USP 1207 and ASTM (F-3287-17) recognized ATC Mass Extraction Technology works on the principle of rarefied gas flow. Testing takes place in vacuum conditions to attain higher sensitivity. This patented technology is particularly suitable for pharmaceutical packaging such as IV-bags, pouches or glass vials. Larger defects and defects as small as 1 μm can be detected with this method. The technology is thereby suitable for laboratory applications as well as for use in production environments allowing stability control as well as 100% automated testing (also in inline machines). FDA laboratories in the US and major pharmaceutical companies have been using the Mass Extraction instruments for over 10 years.

About Pfeiffer Vacuum
Pfeiffer Vacuum (stock exchange symbol PFV, ISIN DE0006916604) is one of the world’s leading providers of vacuum solutions. In addition to a full range of hybrid and magnetically levitated turbopumps, the product portfolio comprises backing pumps, leak detectors, measurement and analysis devices, components as well as vacuum chambers and systems. Ever since the invention of the turbopump by Pfeiffer Vacuum, the company has stood for innovative solutions and high-tech products that are used in the Analytics, Industry, Research & Development, Coating and Semiconductor markets. Founded in 1890, Pfeiffer Vacuum is active throughout the world today. The company employs a workforce of some 3,200 people and has more than 20 sales and service companies as well as 10 manufacturing sites worldwide. For more information, visit

Source: Pfeiffer Vacuum Inc.